# CSL Plasma Inc. – FDA Inspection, May 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/b956c8e7-ea9a-424c-83b1-3b609d4b824e
Source feed: FDA_Inspections

> FDA inspection 1051525 of CSL Plasma Inc., May 11, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1051525
- Company Name: CSL Plasma Inc.
- Inspection Date: 2018-05-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1297798 - 2025-12-31
- FDA Inspection 849991 - 2013-09-19
- [FDA Inspection 741490 - 2011-08-09](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/74d222b5-c769-45fe-ba1a-98a009c9a6ef)
- [FDA Inspection 580389 - 2009-04-27](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/6fc7483c-dd1b-4a71-b030-5e2e27b9944c)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/matthew-j-gretkierewicz/d2b43230-5324-44e0-9cd0-7e40464bf5b0)

Company: https://www.keypedia.com/companies/csl-plasma-inc/d969155a-9249-4a4a-88cb-61918ed1c7c8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
